Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ping An Biomedical CoPASW -6.49%17 Net Current Asset Value is $0.28 as of Sep. 2025, which is 94% below its 10-year median of 4.43. GuruFocus rates PASW with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 630 Manufacturing - Apparel & Accessories companies, Ping An Biomedical Co ranks better than 95.87% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Ping An Biomedical Co's net current asset value per share for the quarter that ended in Sep. 2025 was $0.28.
The historical rank and industry rank for Ping An Biomedical Co's Net Current Asset Value or its related term are showing as below:
PASW'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.44 Med: 4.43 Max: 4.43
Current: 0.44
During the past 5 years, the highest Price-to-Net-Current-Asset-Value Ratio of Ping An Biomedical Co was 4.43. The lowest was 0.44. And the median was 4.43.
PASW's Price-to-Net-Current-Asset-Value is ranked better than 95.87% of 630
companies
in the Manufacturing - Apparel & Accessories industry
Industry Median: 2.885
vs PASW: 0.44
Ping An Biomedical Co (NAS:PASW) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Ping An Biomedical Co Net Current Asset Value Related Terms
Ping An Biomedical Co Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Ping An Biomedical Co's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ping An Biomedical Co Net Current Asset Value Chart
PASW vs DXYN, CULP, UFI: Net Current Asset Value Comparison
For the Textile Manufacturing subindustry, Ping An Biomedical Co's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ping An Biomedical Co Price-to-Net-Current-Asset-Value vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Ping An Biomedical Co's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Ping An Biomedical Co's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $0.28 mean?
Ping An Biomedical Co (PASW) has a Net Current Asset Value of $0.28 as of Sep. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Ping An Biomedical Co and its competitors. This is 94% below median its historical median of 4.43. Over the past decade, Ping An Biomedical Co's Net Current Asset Value has ranged from 0.44 to 4.43. According to the industry distribution chart, Ping An Biomedical Co ranks #26 out of 630 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 4.1%.
Is Ping An Biomedical Co's Net Current Asset Value too high?
Ping An Biomedical Co's current Net Current Asset Value of $0.28 is 94% below median its 10-year median of 4.43. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 4.43. The Manufacturing - Apparel & Accessories industry median Net Current Asset Value is 2.89. Ping An Biomedical Co's value of $0.28 is 90.3% below this industry median. Based on the distribution chart, Ping An Biomedical Co ranks #26 out of 630 companies in the Manufacturing - Apparel & Accessories industry, which is in the top quartile — a strong position relative to peers. Overall, Ping An Biomedical Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Ping An Biomedical Co's Net Current Asset Value compare to DXYN and CULP?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Ping An Biomedical Co ranks #26 out of 630 companies for Net Current Asset Value. This places Ping An Biomedical Co in the top 4% of its industry — outperforming the majority of peers. The industry median Net Current Asset Value is 2.89. Ping An Biomedical Co's value of $0.28 is 90.3% below this benchmark. Historically, Ping An Biomedical Co's own Net Current Asset Value has ranged from 0.44 to 4.43 over the past decade. While the company's 10-year median is 4.43 vs. the industry median of 2.89, Ping An Biomedical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Manufacturing - Apparel & Accessories company?
The median Net Current Asset Value among Manufacturing - Apparel & Accessories companies is 2.89, based on 630 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ping An Biomedical Co's current Net Current Asset Value of $0.28 is 90.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Ping An Biomedical Co and its competitors. For the Manufacturing - Apparel & Accessories industry, the median Net Current Asset Value is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ping An Biomedical Co's current Net Current Asset Value is $0.28, which is 94% below median its own 10-year median of 4.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ping An Biomedical Co stock overvalued right now?
Ping An Biomedical Co (PASW) has a current Net Current Asset Value of $0.28. The current Net Current Asset Value is $0.28, which is 94% below median its 10-year median of 4.43 and 90.3% below the Manufacturing - Apparel & Accessories industry median of 2.89. Ping An Biomedical Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Ping An Biomedical Co (PASW), the current Net Current Asset Value is $0.28 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.
17GF Score
Get the complete analysis for PASW
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PASW has been successfully added to your 
